If you have been following the PDA conversation for the past few years, you have probably noticed that the name keeps changing. Some people still say "Pathological Demand Avoidance." Some say "Persistent Demand Avoidance." Some have moved to "Pervasive Drive for Autonomy." And on this site, we mostly say "demand sensitivity." The alphabet of alternatives is not just semantic fussiness. Each one of these terms comes from a different place in the field and reflects a different concern about what the original word was doing. This post walks through the two most significant alternatives to "Pathological Demand Avoidance" that you are likely to encounter, where each came from, who uses them, and what each one gets right.
If you are new to the naming question entirely, start with our broader overview at PDA, Demand Avoidance, Demand Sensitivity: Why the Name Matters. This post goes deeper on the two specific alternatives that have gained the most traction in recent years.
The original term, Pathological Demand Avoidance, was coined by British child psychologist Elizabeth Newson in the 1980s. Newson was working with children who presented with autism-related features but whose profile did not match what was then called typical autism. The defining feature she identified was an anxiety-driven, obsessive resistance to everyday demands. She called it "pathological" to signal that the pattern was severe enough to warrant clinical attention and that it was not simply wilful misbehavior. In the clinical context of the 1980s, the word was a flag for legitimacy. It said to other clinicians, take this seriously, this is not ordinary defiance.
That framing served the field for decades. It got PDA recognized in British pediatric psychiatry, it gave clinicians and parents a term they could use in conversations with schools and medical teams, and it connected PDA to the broader autism research literature. The word was doing real work. And then, gradually, the world changed around it.
Two things happened over the course of the 2000s and 2010s that made the word "pathological" increasingly uncomfortable for people inside the PDA community.
First, the autistic rights movement built out a broader critique of medicalized language. The argument, made by autistic adults and disability scholars, was that describing neurological difference as "pathology" positions the person as broken and the goal of intervention as making them closer to normal. Autism organizations led by autistic people began pushing back on diagnostic language that positioned autistic traits as deficits to be corrected. That conversation spilled into the PDA community, where the word "pathological" started to feel like a holdover from an older model of disability.
Second, adults started identifying with the PDA profile in larger numbers. Many of these adults had not been recognized as children. They were encountering the term for the first time as grown-ups who had spent decades thinking they were lazy, broken, or uniquely unable to function. Discovering a word that named the pattern was often a profound moment of recognition. But the word they were discovering called them "pathological." For a person who had just realized that the thing they had been fighting their whole life was neurological, the word landed as one more piece of evidence that they were broken. Not the emotional tone most adults wanted from the name of their nervous system.
These two pressures pushed the field to look for alternatives. The two most prominent alternatives today are Persistent Demand Avoidance and Pervasive Drive for Autonomy.
In 2022, the PDA Society, which is the main advocacy and education organization for PDA in the United Kingdom, formally announced a shift in the terminology they would use going forward. They dropped "Pathological" and replaced it with "Persistent." Same acronym. Different first word. The change was not universally adopted. It was announced, and the community decided what to do with it.
The logic was straightforward. The acronym "PDA" had become the widely used label, well beyond clinical circles. Changing the acronym entirely would have broken years of accumulated search visibility, conversation, documentation, and community recognition. Keeping "PDA" but changing what the P stands for preserved the continuity while addressing the specific complaint about "pathological." It was a surgical fix.
"Persistent" is a descriptive word that carries far less judgment than "pathological." It points to a quality of the behavior, namely that it keeps happening, that it is not a one-off, that it is a consistent pattern rather than an occasional reaction. For parents, clinicians, and educators who had been describing the profile for years and needed a word that did not sound accusatory, "Persistent Demand Avoidance" offered a softer landing.
It also retained the utility of the term for people searching for help. A parent typing "PDA autism" into Google, or a clinician looking up the profile in continuing education materials, still found the same body of work. The rebrand did not orphan anyone from the existing resources. That continuity matters in a field where most of the useful information is still scattered across a small number of blogs, books, and nonprofit sites.
The word "avoidance" is still in there, and avoidance is still a behavioral description, not a mechanism description. A nervous system that responds to demands as threats is not really "avoiding" anything in the ordinary sense of the word. Avoidance implies a choice to steer away from something unpleasant. The actual mechanism is closer to a threat response that blocks voluntary action, which is not the same as avoidance. "Persistent Demand Avoidance" is a more polite version of the old framing but it still defines the profile by the visible behavior rather than the underlying nervous system state. That is a real limitation. Clinicians reading the term are still primed to target the behavior, even though the behavior is a downstream effect of something much further upstream.
Also worth saying: the "Persistent" rebrand happened in the UK and it has not moved uniformly across the Atlantic. Many American clinicians, researchers, and adult self-advocates still use "Pathological" or have moved directly to newer alternatives like "Pervasive Drive for Autonomy" or "demand sensitivity," skipping the "Persistent" stop entirely. The geography matters. If you are a clinician in the United States, you will encounter all four terms in use and the choice of which one to use will be a cultural as much as a clinical decision.
The "Persistent" rebrand is a meaningful improvement on "Pathological" but it keeps the same framing of the profile as a behavior problem. It is a fix to a word, not a fix to the mental model.
While the PDA Society was working on the "Persistent" change, a different reframe was emerging from a different part of the community. "Pervasive Drive for Autonomy," often abbreviated PDA to preserve the acronym, came from adult autistic self-advocates. The term was championed most visibly by Tomlin Wilding, an autistic advocate and educator whose writing and speaking on the topic helped popularize the reframe. It flipped the entire orientation of the original term.
"Pathological Demand Avoidance" describes the profile as an absence of something (compliance). "Pervasive Drive for Autonomy" describes it as the presence of something (a need). The mechanism is the same. The direction of the description is opposite.
This is the first alternative that reframes the profile as a strength rather than a deficit. Instead of "this person cannot do what they are told," the framing becomes "this person has a deep, wired need to be in charge of their own life." For many adults encountering the profile in themselves, this version of the language is the first one that does not feel like an accusation. It names a drive, not a failure. It describes what the nervous system is reaching for, not just what it refuses to do.
That matters because the strengths-based framing is more accurate to the internal experience. People with this profile are not passively avoiding demands. They are actively, intensely reaching for autonomy. The reaching is the thing. The avoidance is a symptom of what happens when the reaching gets blocked. "Pervasive Drive for Autonomy" names the primary experience and treats the observable avoidance as secondary, which is closer to how the mechanism actually works from the inside.
It also resonates with the broader neurodiversity movement's preference for language that describes neurodivergent traits as differences rather than deficits. This matters for community identification. An autistic adult who has spent years resisting the word "pathological" may feel immediate relief at the word "drive." Drive is something people admire. Drive is something people build careers on. Drive is something you can orient your life around instead of fighting.
The reframe is emotionally powerful but it has a clinical cost. By centering the drive for autonomy as the defining feature, the framing softens the nervous-system-level threat response that makes this profile so hard to live with. The word "drive" implies something a person is choosing, something motivational, something that could be channeled or harnessed. But the underlying mechanism is not a drive in the ordinary sense. It is a protective reflex firing in response to perceived loss of autonomy. The reflex is involuntary. The word "drive" makes it sound voluntary.
This matters more for clinicians than for self-advocates. If you are an autistic adult using "Pervasive Drive for Autonomy" to describe your own experience, the drive framing probably fits your lived reality and is useful for self-identification. If you are a clinician trying to communicate with a skeptical colleague about why your client is locked up on the couch, "drive for autonomy" may not convey the involuntary, reflexive, threat-response quality of what is actually happening. The word can sound like motivated behavior, which is exactly what the profile is not.
There is also a practical issue. Some clinicians and researchers have pushed back on "Pervasive Drive for Autonomy" because they argue it obscures the anxiety-driven core of the profile that Newson originally identified. If the drive for autonomy were the full story, the person would simply exercise autonomy. What actually happens is that the nervous system goes into threat mode when autonomy is perceived to be under threat, and that threat response is what blocks action. The drive framing can read as if the person is just very independent, when the lived experience is closer to being paralyzed by a threat cascade. Both things are true. The framing emphasizes one and mutes the other.
"Persistent Demand Avoidance" and "Pervasive Drive for Autonomy" are responding to the same underlying problem (the word "pathological") but they are trying to fix different parts of it. "Persistent" fixes the judgmental tone while keeping the original framing and acronym intact. "Pervasive Drive for Autonomy" fixes the framing itself while also keeping the acronym. One is a word swap. The other is a paradigm swap. They are not mutually exclusive. A clinician could use "Persistent Demand Avoidance" in professional communication with colleagues who are used to the older language, and use "Pervasive Drive for Autonomy" in community-facing writing or self-advocacy contexts. The terms serve different purposes in different rooms.
Both are improvements on the original. Both have limitations. Neither fully captures the nervous system mechanism that makes this profile what it is.
On this site, we mostly use "demand sensitivity" as the everyday term, alongside "PDA" where the clinical recognition matters. We arrived there after using all of these alternatives in clinical settings and watching how each one landed with different populations.
"Demand sensitivity" describes the mechanism directly. It says: this nervous system is more reactive to demands than most nervous systems are. That is the underlying fact from which everything else follows. The word "sensitivity" is borrowed from how the field already talks about other nervous system features, like sensory sensitivity or rejection sensitivity. It positions the profile as a dimension of how the nervous system processes information, not as a behavior to be corrected or a drive to be celebrated. It is neither an accusation nor a reframe. It is a description.
We also like that "demand sensitivity" is legible to people who have never heard of PDA. A new reader can infer roughly what it means from the words themselves. That is not true of "Pathological Demand Avoidance," which requires explanation, and not quite true of "Pervasive Drive for Autonomy," which requires at least one follow-up question. "My nervous system is very sensitive to demands" is a sentence that almost anyone can understand on first encounter, and that accessibility matters for a profile that is still largely invisible to the people living with it.
None of this means "demand sensitivity" is the right term for everyone. Adults who found recognition and identity in "Pervasive Drive for Autonomy" may prefer that framing for self-advocacy. Clinicians working in research contexts may need to use "Pathological Demand Avoidance" to connect with the existing literature. Parents and educators in the UK may find that "Persistent Demand Avoidance" is what their local community uses and changing would create unnecessary friction. The terms can coexist. Each one serves a purpose in some context.
Use the word that works in the room you are in. If you are writing a chart note, use language that is clinically defensible and that future clinicians will understand. If you are talking to a newly diagnosed adult, use the term that fits the emotional tone of the conversation. If you are training a residential staff, use the term that maps onto the framework you are teaching. If you are writing about this in public, name your term of choice and explain why.
What matters is not which word you pick. What matters is that you understand what each word emphasizes and what it leaves out, and that you choose deliberately based on who you are talking to and what you are trying to communicate. The naming question is not a debate to be won. It is a tool kit to be used.
For more on how we think about this, the RELATE framework page explains the clinical structure we built on top of the mechanism, which is the same mechanism regardless of what you call it. The demand sensitivity guide is our plain-language explainer for the term we use most often. And the broader naming overview covers the conversation as a whole.